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group with severe pancreatitis (35 vs. 16%; p = 0.051, odds 
ratio = 2.917, 95% confidence interval = 1.089–7.811). There 
was no significant correlation between TLR4 polymorphisms 
and the acute pancreatitis itself, but nonsignificantly in-
creased frequencies of Asp299Gly and Thr399Ile heterozy-
gotes among patients with severe infected pancreatic ne-
crosis could be observed relative to the patients with mild 
pancreatitis.  Conclusions: Determination of the frequency 
of IL-8 polymorphism in acute pancreatitis may be informa-
tive and may provide further evidence concerning the role 
of IL-8 in the severe form of this disease. The possible role of 
TLR4 polymorphism in the outcome of severe acute pancre-
atitis requires further investigations in a larger series of pa-
tients. 
 
Copyright © 2006 S. Karger AG, Basel and IAP 
 Introduction 
 The activation of polymorphonuclear granulocytes 
and monocytes/macrophages is an early event during se-
vere acute pancreatitis. Activated leukocytes are thus a 
pathogenetic factor as regards the severity of the disease 
 [1, 2] . Interleukin-8 (IL-8) is an important neutrophil-ac-
tivating cytokine and is a potent chemoattractant  [3] , and 
increased levels of this cytokine have been demonstrated 
in acute pancreatitis  [4, 5] . Although the clinical course 
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 Abstract 
 Background/Aim: Activated granulocytes and inflamma-
tory mediators of the innate immune response play funda-
mental roles in the pathogenesis of acute pancreatitis. We 
studied whether polymorphisms of interleukin-8 (IL-8) and 
Toll-like receptor 4 (TLR4) genes correlate with the severity 
of acute pancreatitis.  Methods: Patients with acute pancre-
atitis (n = 92) were grouped according to the severity of the 
disease on the basis of the Ranson scores. Healthy blood 
 donors (n = 200) served as controls. The IL-8 –251 gene 
 polymorphism was analyzed by amplification-refractory 
mutation system; the single-nucleotide polymorphisms 
(Asp299Gly and Thr399Ile) of TLR4 were investigated by us-
ing a real-time polymerase chain reaction method with melt-
ing point analysis.  Results: The IL-8 A/T heterozygote mu-
tant variants were detected with a significantly higher 
frequency among the patients with severe pancreatitis than 
among the healthy blood donors (60 vs. 42%; p = 0.0264, 
odds ratio = 2.071, 95% confidence interval = 1.101–3.896), 
while the frequency of the normal allelic genotype (TT) was 
higher among the patients with mild pancreatitis than in the 
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of acute pancreatitis is often mild with only minimal or-
gan dysfunction, a significant proportion of these pa-
tients develop severe disease often associated with local 
inflammation, multiple organ failure, and infections. 
The levels of cytokines depend on a number of factors, 
including the genetic background, e.g., the nucleotide 
polymorphisms of cytokine genes. 
 Genetic polymorphisms within the promoter of the 
inflammation-related cytokine genes are considered to 
influence the expressions of these cytokines, and there 
are numerous infectious and noninfectious diseases, 
where these polymorphic changes have been shown to 
correlate with the disease susceptibility or the outcome of 
the disease  [6] .  
 It has been reported  [7] that a T-to-A mutation in the 
–251 promoter region is accompanied by an increased
IL-8 production. Therefore, we hypothesized that poly-
morphism of the IL-8 gene may influence disease suscep-
tibility and the severity of acute pancreatitis. 
 Other factors regulating the innate immune response 
may also be involved in the complications of acute pan-
creatitis. One of the central regulators is Toll-like recep-
tor 4 (TLR4) which plays an important role in subsequent 
proinflammatory reactions  [8] . TLR4 interacts not only 
with lipopolysaccharide, but also with heat shock pro-
teins 60 and 70. Two common single-nucleotide poly-
morphisms have been found in the coding region of the 
human TLR 4 gene in exon 3 which are in tight linkage 
disequilibrium  [9] . They lead to amino acid exchanges in 
positions 299 (Asp299Gly) and 399 (Thr399Ile). An A-to-
G conversion at position 12874 replaces Asp299 by a Gly 
residue, whereas a C-to-T conversion at position 13174 
replaces Thr399 by an Ile residue. It has been shown that 
the presence of Gly299 and Ile399 alters the structure of 
the extracellular domain of TLR4 which may influence 
the ligand binding and result in a loss of function  [10] . An 
enhanced risk of septic shock has been reported in pa-
tients with Asp299Gly and Thr399Ile mutations  [11] . We, 
therefore, considered it of interest to investigate whether 
the modulated immune response caused by the polymor-
phisms of TLR4 has any association with the severity of 
acute pancreatitis. 
 Patients and Methods 
 Patients 
 The patient group consisted of 92 patients with acute pancre-
atitis. The criteria for the diagnosis of acute pancreatitis were a 
clinical history consistent with the disease, appropriate radiolog-
ical evidence, and a serum amylase level  1 660 U/l. The patients 
entered this prospective study at the Department of Surgery and 
the First Department of Internal Medicine of the Albert Szent-
Györgyi Medical Center of the Szeged University between March 
2003 and January 2005. The study was approved by the Institu-
tional Review Board of the Faculty of Medicine. The patients were 
classified as having mild or severe pancreatitis according to the 
original criteria of Ranson  [12]: mild pancreatitis had patients 
with fewer than three positive prognostic signs (n = 42); severe 
pancreatitis had patients with three or more positive prognostic 
signs (n = 50). Patients with severe acute necrotizing pancreatitis 
were divided into aseptic (n = 28) or infected (n = 22) groups on 
the basis of the results of bacterial cultures of the necrotic pancre-
atic tissue sampled during surgery or ultrasound- or CT-guided 
biopsies. In 49 patients, the acute pancreatitis was caused by alco-
hol ( 1 80 g/day); in 35 patients, the cause was cholelithiasis, and 
in 8 patients no cause could be identified (these cases were classi-
fied as idiopathic). 
 During hospitalization, laboratory parameters, including 
erythrocyte sedimentation rate, leukocyte count, hematocrit, Na, 
K, Ca, P, urea, base excess, amylase, glucose, bilirubin, alkaline 
phosphatase, C-reactive protein, and procalcitonin, were deter-
mined. All patients repeatedly underwent chest X-ray, abdominal 
X-ray, ultrasound, and contrast-enhanced abdominal CT exami-
nations. The diagnosis of acute necrotizing pancreatitis was based 
on the typical CT findings. Ultrasound-guided fine-needle aspi-
ration from the necrotic pancreatic tissue and bacterial culturing 
were carried out, in parallel with hemoculture. Endoscopic retro-
grade cholangiopancreatography was performed when biliary 
pancreatitis was suspected. In patients with biliary tract lithiasis, 
stone extraction was carried out following endoscopic sphincter-
otomy. 
 In all patients conservative treatment was indicated, including 
fluid and electrolyte resuscitation; in the severe cases this was 
supplemented with cardiac and respiratory support, total paren-
teral nutrition, analgesics, and H-2 receptor blocking drugs. Pro-
phylactic antibiotic treatment (imipenem or ciprofloxacin com-
bined with metronidazole) was introduced only in cases with 
pancreatic necrosis proved by contrast-enhanced CT scan. No an-
tibiotic treatment was used in patients with mild edematous pan-
creatitis. In cases with septic pancreatic necrosis (demonstrated 
by ultrasound- or CT-guided fine-needle aspiration), antibiotics 
were used on the basis of the antibiogram. 
 After having positive bacteriological results and a procalcito-
nin level  1 3 ng/ml, surgical intervention was indicated in all of 
the infected cases which included wide-ranging pancreatic necro-
sectomy and continuous lavage with multiple drainage. The in-
traoperative bacteriological examinations confirmed the bacte-
rial results obtained with fine-needle aspiration. 
 Systemic inflammatory response syndrome (SIRS) was de-
fined according to the criteria of the American College of Chest 
Physician/Society of Critical Care Medicine consensus confer-
ence  [13] . Patients were confirmed as being SIRS positive, when 
two or more criteria were fulfilled on 2 or 3 consecutive days of 
the observation period  [14] . No SIRS was observed among the 
patients of the mild pancreatitis group (n = 42); 7 of the 50 pa-
tients with severe pancreatitis were classified as being SIRS neg-
ative, and in the remaining 43 patients of this group SIRS devel-
oped. 
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 Healthy Subjects 
 The control cohort consisted of a random, unrelated popula-
tion sample of 200 healthy blood donors. All cases and controls 
were of Hungarian ethnic origin and resident in Hungary. 
 DNA Isolation 
 Genomic DNA purified from peripheral blood (Roche Diag-
nostics, Mannheim, Germany) was used. The leukocyte DNA was 
isolated according to the manufacturer’s instructions using a 
High Pure PCR Template Preparation Kit (cat. No. 1796828; 
Roche Diagnostics). The genomic DNA was stored at –20  °  C until 
further use. 
 Analysis of the polymorphisms was based on polymerase 
chain reaction (PCR) techniques performed either by means of a 
thermal cycler (GeneAmp PCR System 2700; Applied Biosystems, 
Foster City, Calif., USA) or a light cycler (LightCycler Instrument; 
Roche Diagnostics). 
 IL-8 Polymorphism 
 A single-nucleotide T ] A polymorphism at –251 nt relative to 
the transcription start site accompanied by an increased IL-8 pro-
duction was typed by means of the amplification-refractory muta-
tion system (ARMS)  [7] . The allele-specific primers were: 5  -CCA 
CAA TTT GGT GAA TTA TCA AT-3  (–251A) and 5  -CCA CAA 
TTT GGT GAA TTA TCA AA-3  (–251T). The consensus primer 
was 5  -TGC CCC TTC ACT CTG TTA AC-3  , giving a PCR prod-
uct of 336 bp. In each reaction a second set of primers for exon 3 
of the HLA-DRB1 gene (forward 5  -TGC CAA GTG GAG CAC 
CCA A-3  , reverse 5  -GCA TCT TGC TCT GTG CAG AT-3  , prod-
uct size 796 bp) was used as a control for the PCR efficiency. Reac-
tions were carried out using Advantage-GC cDNA polymerase 
mix and buffer (Clontech, Palo Alto, Calif., USA) under the fol-
lowing conditions: 96  °  C for 120 s; four cycles of 96  °  C for 35 s, 
68  °  C for 45 s, 72  °  C for 35 s; four cycles of 96  °  C for 35 s, 65  °  C for 
45 s, 72  °  C for 45 s; four cycles of 96  °  C for 35 s, 62  °  C for 45 s, 72  °  C 
for 55 s; ten cycles of 96  °  C for 35 s, 58  °  C for 45 s, 72  °  C for 65 s; 
ten cycles of 96  °  C for 35 s, 55  °  C for 45 s, 72  °  C for 75 s; four cycles 
of 96  °  C for 35 s, 52  °  C for 45 s, 72  °  C for 85 s; four cycles of 96  °  C 
for 35 s, 50  °  C for 45 s, 72  °  C for 90 s, and 72  °  C for 5 min. 
 TLR4 Genotyping (A12874G and C13174T) 
 The real-time PCR contained 1   l (20–80 ng) genomic DNA 
in a reaction volume of 10   l. A concentration of 0.5   mol/l of the 
primers (TLR-4 forward 5  -CAG GTG CAT TTA AAG AAA TTA 
GGC-3  , TLR-4 reverse 5  -CCA AGA AGT TTG AAC TCA TGG 
TAA-3  ), 0.2   mol/l of each fluorescence probe (TIB Molbiol Syn-
theselabor, Berlin, Germany), 1.5   l (25 mmol/l) MgCl 2 , and 1   l 
reaction buffer (10 ! LightCycler DNA master hybridization 
probes; Roche Diagnostics) were used. The sensor probe for 
A12874G (SNP1 sensor) was labeled with fluorescein at the 3  end, 
and the anchor probe (SNP1 anchor) specific for the G allele was 
labeled with LightCycler Red 640 at the 5  end (SNP1 sensor 5  -
GAC CAT TGA AGA ATT CCG ATT AGC ATA CTT AGA CT-3  , 
SNP1 anchor 5  -CTA CCT CGA TGA TAT TAT TGA CTT ATT 
TAA TTG TT-3  ). The sensor probe for C13174T (SNP2 sensor) 
was labeled with fluorescein at the 3  end, and the anchor probe 
(SNP2 anchor) specific for the T allele was labeled with LightCy-
cler Red 705 at the 5  end (SNP2 sensor 5  -CTT GAG TTT CAA 
AGG TTG CTG TTC TCA AAG T-3  , SNP2 anchor 5  -ATT TTG 
GGA CAA CCA GCC TAA AGT AT-3  ). 
 The PCR parameters for this gene on the LightCycler were as 
follows: initial denaturation at 94  °  C for 1 min and 40 cycles of 
denaturation (95  °  C for 0 s, 20  °  C/s), annealing (55  °  C for 10 s, 
20  °  C/s), and extension (72  °  C for 25 s, 20  °  C/s). Melting curve 
analysis: 1 cycle at 95  °  C for 0 s, 52  °  C for 40 s, followed by an in-
crease of the temperature to 80  °  C at a slope of 0.1  °  C/s. 
 Statistics 
 The level of significance of the genotype frequency was ana-
lyzed by using the Fisher exact test or the    2  test, as appropriate. 
p  ! 0.05 indicated statistical significance. The relationship be-
tween genotypes and disease severity is presented as odds ratio 
(OR), with a 95% confidence interval (CI). All statistical calula-
tions were performed with the GraphPad Prism 4.0 statistical pro-
gram (GraphPad Software, San Diego, Calif., USA). The genotype 
frequencies for each polymorphism were tested for deviation 
from the Hardy-Weinberg equilibrium by the    2  test, with 1 de-
gree of freedom.  
 Results 
 IL-8 Polymorphism 
 Figure 1 shows representative results for IL-8 genotyp-
ing. To detect the nucleotide swap, ARMS was used. By 
means of the two allele-specific primers, the homozygote 
mutant (AA) and the heterozygote (AT) and the homo-
zygote (TT) variants (336-bp products) were well distin-
guishable. To control the effectiveness of the PCR reac-
tion, the HLA-DRB1 exon 3 gene was also demonstrated 
in each case (product size 796 bp). 
489 bp
404 bp
331 bp
242 bp
190 bp
147 bp
110 bp
501 bp
IL-8  336 bp
HLA-DRB1  796 bp
1 2 3 4 5 6 7
 Fig. 1. PCR/ARMS analysis of the IL-8 –251 polymorphism. Lanes 
1 and 2 correspond to genotype AA, lanes 4 and 5 to heterozygote 
genotype AT, and lanes 6 and 7 to genotype TT (366 bp). Lane 3 
shows a molecular weight marker with band sizes of 501–110 bp. 
The upper band corresponds to a HLA-DRB1 gene product 
(796 bp) as a control. 
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 The distribution of the IL-8 genotypes was in accor-
dance with the Hardy-Weinberg equilibrium both in the 
control population (   2  = 2.308; p = 0.128) and in the pa-
tient group (   2  = 0.049; p = 0.8248). 
 The genotypic distribution of the –251 polymor-
phism of the IL-8 gene is shown in  table 1 . There was a 
significant difference in genotype distribution between 
the pancreatitis patients overall and the healthy controls 
(p = 0.020). When the patients were stratified according 
to the disease severity, a significant difference was ob-
served only between the controls and the patients with 
severe pancreatitis (p = 0.004) and not between the con-
trols and the patients with mild pancreatitis, when the 
genotypes were taken into consideration. Thereafter, we 
compared the numbers of AT heterozygotes and AA ho-
mozygotes (high IL-8 producers) among the patients 
with severe pancreatitis and the controls. As shown in 
 table 1 , there was a higher frequency of the A/T geno-
type among the patients with severe disease as com-
pared with the controls: 30 of the 50 patients (60%) ver-
sus 84 of the 200 the healthy controls (42%; p = 0.0264; 
OR = 2.071, 95% CI = 1.101–3.896). There was also a sig-
nificant difference between the patients with the severe 
and those with the mild form of the disease (p = 0.0232; 
OR = 2.7, 95% CI = 1.157–6.303). Similarly, the carriage 
of the high IL-8 secreting allele (IL-8 A) was significant-
ly different between the patients with severe pancreatitis 
(54%) and the healthy blood donor group (38%; p = 
0.004; OR = 1.915, 95% CI = 1.231–2.980), though the 
number of homozygotes itself was relatively low. Con-
versely, the prevalence of the IL-8 TT wild-type geno-
type was significantly lower in the group of patients with 
severe pancreatitis (16%) than in the healthy control 
group (41%; p = 0.0009; OR = 3.648, 95% CI = 1.628–
8.177) and even lower than in the group of patients with 
mild panreatitis (35 vs. 16%; p = 0.051; OR = 2.917, 95% 
CI = 1.089–7.811). 
 TLR4 Polymorphism 
 The LightCycler protocol described by Hamann et al. 
 [15] allows the simultaneous detection of the two poly-
morphisms. C13174T is generally cosegregated with 
A12874G.  Figure 2 shows a representative experiment of 
the real-time PCR genotyping of TLR4 in 2 patients and 
a control subject. Patient A is heterozygous for both 
A12874G and C13174T, while patient B reflects the wild 
type for both genotypes. The LightCycler PCR for the ge-
notyping of both TLR4 polymorphisms simultaneously 
in a single-tube reaction gave rise to melting peaks at 
64  °  C and 67  °  C for A12874G and C13174T, respectively, 
for wild-type samples. The heterozygous samples showed 
an additional melting peak at 61  °  C ( fig. 2 ). 
 TLR4 Asp299Gly Polymorphism 
 The distribution of the TLR4 12874 A/G genotypes 
was not in accordance with the Hardy-Weinberg equilib-
rium either in the control group (n = 75) or in the patient 
group (n = 92;    2  = 6.409, p = 0.0114, and    2  = 10.34, p = 
0.0013, respectively). 
 The genotypic distribution of the TLR4 12874 A/G 
polymorphism of the TLR4 gene is shown in  table 2 . No 
significant difference in genotype distribution was found 
between the pancreatitis patients overall and the healthy 
controls (p = 0.6507), nor between the patients with severe 
pancreatitis and the healthy controls (p = 0.8872). How-
ever, it is striking that in spite of the low number of A/G 
heterozygotes, 6 of the 7 heterozygotes were found in the 
severe pancreatitis group (6 of the 50), in contrast to only 
1 heterozygote among the 42 patients with mild pancre-
atitis. However, this result is not statistically significant. 
TT AT AA p
Mild, n (%) 15/42 (35) 15/42 (35) 12/42 (28) 0.22 (NS)a
Severe, n (%) 8/50 (16) 30/50 (60) 12/50 (24) 0.004a
p = 0.0009 vs. controlsb p = 0.0264 vs. controlsb
p = 0.051 vs. mildb p = 0.0232 vs. mildb
Total, n (%) 23/92 (25) 45/92 (48) 24/92 (26) 0.020a
Controls, n 
(%)
82/200 (41) 84/200 (42) 34/200 (17)
a Chi-square test versus controls. 
b Fisher test.
Table 1. IL-8 –251 genotypes in patients 
with acute pancreatitis
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 TLR4 Thr399Ile Polymorphism 
 The distributions of the 13174 C/T genotypes of the 
TLR4 gene in the controls (n = 75) and in the patients 
overall (n = 92) were in Hardy-Weinberg equilibrium 
(   2  = 0.610, p = 0.434, and    2  = 3.05, p = 0.080). 
 The genotypic distribution of the TLR4 13174 C/T poly-
morphism of the TLR4 gene is shown in  table 3 . No sig-
nificant difference in genotype distribution was found be-
tween the pancreatitis patients overall and the healthy 
controls (p = 0.209), nor between the patients with severe 
pancreatitis and the controls (p = 0.4662). Again, it is strik-
ing that in spite of the low number of C/T heterozygotes, 
6 of the 7 heterozygotes were found in the patients with 
severe pancreatitis (6 of the 50), in contrast to only 1 het-
erozygote among the 42 patients with mild pancreatitis. 
 Discussion 
 Systemic inflammation triggered by acute pancreatitis 
involves multiple pathways and evidently cannot be ex-
plained by the action of a single mediator. Oxidative 
stress and cytokines appear to be of particular impor-
tance  [1, 2] . 
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 Fig. 2. Representative derivative melting curves of a heterozygous type sample (patient A) and a wild-type 
 sample (patient B) for A12874G and C13174T polymorphisms within the TLR4 gene. C = Control sample. 
Table 2. TLR4 Asp299Gly genotypes in patients with acute pan-
creatitis
AA AG GG p
Mild, n (%) 41/42 (97.6) 1/42 (2) 0/42 0.3223a
Severe, n (%) 43/50 (86) 6/50 (12) 1/50 (2) 0.8872a
Total, n (%) 84/92 (91) 7/92 (7.6) 1/92 (1) 0.6507a
Controls, n (%) 64/73 (87.6) 7/73 (9.5) 2/73 (2.7)
a Chi-square test: nonsignificant versus controls.
Table 3. TLR4 Thr399Ile genotypes in patients with acute pancre-
atitis
CC CT TT p
Mild, n (%) 41/42 (97.6) 1/42 (2.3) 0/42 0.136a
Severe, n (%) 43/50 (86) 6/50 (12) 1/50 (2) 0.466a
Total, n (%) 85/92 (92.3) 6/92 (6.5) 1/92 (1) 0.209a
Controls, n (%) 63/73 (86.4) 10/73 (13.6) 0/73
a Chi-square test: nonsignificant versus controls.
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 Previous studies of proinflammatory cytokine gene 
variations gave controversial results to reveal their dis-
ease-predicting role and a close relationship with the de-
velopment of a severe attack of acute pancreatitis  [16–18] . 
Although the importance of neutrophil activation and 
IL-8 production in acute pancreatitis has been clearly 
demonstrated  [4, 5] , data have not been reported in con-
nection with acute pancreatitis and IL-8 polymorphism. 
The present findings are, therefore, the first demonstra-
tion of this association between a high –251 A allele fre-
quency and severe acute pancreatitis. IL-8 is a crucial cy-
tokine in the pathogenesis of pancreatitis. As a member 
of the SIRS  [13, 14] , acute pancreatitis is associated with 
massive recruitment of phagocytes, particularly neutro-
phils, not only locally, but also by a systemic activation of 
neutrophils and monocytes. This also contributes to the 
systemic effects characterizing the SIRS. Accordingly, we 
presume that a predisposition to a higher IL-8 response 
to the stimulus following tissue necrosis may likewise be 
a factor predisposing to the severe complications of pan-
creatitis. There was a significantly higher frequency of 
the A/T genotype among  our patients with severe acute 
pancreatitis than in the healthy subjects without gastro-
intestinal problems. This genotype reflects a higher IL-8-
producing ability  [7, 19] . Conversely, the TT genotype – 
with a relatively lower IL-8-producing potential – oc-
curred significantly more frequently among the healthy 
controls and even in the group of patients with mild pan-
creatitis. It is noteworthy that only 1 of the patients in the 
severe pancreatitis group with TT genotypes (8 of these 
50 patients) showed the symptoms of the SIRS. Our pa-
tients included only a few individuals who carried the AA 
genotype which is very probably a reflection of the rela-
tively small number of patients investigated to date. The 
higher incidence of the –251 AT genotype, with a con-
comitantly higher IL-8-producing potential, draws the 
attention to the importance of the genetic determination 
of the IL-8 production in acute pancreatitis. It is very like-
ly that merely one polymorphism cannot determine the 
final outcome of the disease. Patients carrying the A al-
lele may be possibly at a higher risk of developing the se-
vere form of acute pancreatitis, and once it has developed, 
the high-IL-8-producing genotype exacerbates inflam-
matory processes with more severe consequences of the 
disease. The A allele, therefore, appears to confer risk as 
a dominant factor without a dose effect. 
 The genotype distribution of IL-8 –251 was confirmed 
to be in accordance with the Hardy-Weinberg equilibri-
um in spite of the fact that it was distorted in the controls 
and in the mild pancreatitis cases (p = 0.128 and p = 0.07, 
respectively), but still above the level of significance. Ac-
cordingly, inappropriate subject selection and incorrect 
genotyping of the polymorphism were unlikely. The ef-
fect of population stratification appears very limited in 
Hungary, in contrast to multiethnic countries such as the 
USA. The distribution of the IL-8 genotypes in our con-
trol subjects seems to be rather more similar to that in the 
Japanese  [20] than to that in the Western European  [21] 
population. One limitation of this study is the small size 
of the patients groups. Further studies using larger co-
horts will, therefore, be necessary to validate our find-
ings. 
 We did not find significant differences in TLR4 
Asp299Gly and/or TLR4 Thr399Ile polymorphisms be-
tween the patients and the healthy controls in any form 
of acute pancreatitis investigated. However, the A/G gen-
otype and the T/C genotype demonstrated a higher fre-
quency among the patients with severe acute pancreatitis 
as compared with the patients with mild pancreatitis or 
with the controls, but the difference was not statistically 
significant. It is tempting to speculate why, in spite of the 
low frequency of heterozygote mutants, almost all these 
cases (6 of the 7) were observed among severely ill pa-
tients who suffered from a severe, infected form of acute 
necrotizing pancreatitis with multiple organ failure. The 
relatively small size of the subgroup cohorts warrants 
further investigation. As the allele frequencies of the 
TLR4 polymorphisms are generally low (9–13%), the im-
pact of this rare mutation on disease susceptibility could 
only be clarified by the performance of larger studies. 
Hence, we suggest that a carrier state of either TLR4 
Asp299Gly or TLR4 Thr399Ile heterozygotes might be a 
risk factor for the development of severe septic necrotiz-
ing pancreatitis. It may be suggested that these single-
nucleotide polymorphisms in TLR4 genotypes make the 
patients more susceptible to complications of severe sep-
tic conditions. It has recently been shown that carriers of 
TLR4 receptor mutations are at an increased risk of septic 
shock  [15]. It might be that the impaired recognition of 
either lipopolysaccharide or even of heat shock proteins 
could lead to a weaker resistance of the host. Heat shock 
proteins also play an important role in the pathomecha-
nism of acute pancreatitis  [22] . 
 Because of the small number of subjects involved in 
the present investigation, these results should be used 
with caution, but a TLR4 polymorphism appears to mer-
it further study in a larger series of patients in order to 
validate our findings. 
 Our pilot study involved 92 cases of acute pancreatitis, 
and the conclusion must, therefore, be considered only a 
 Hofner  /Balog  /Gyulai  /Farkas  /
Rakonczay  /Takács  /Mándi  
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preliminary one. However, continuing IL-8 genotype as-
sessments may provide important clinical evaluation cri-
teria with which to guide treatment or to identify popula-
tions at risk of severe acute pancreatitis. 
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